US Sees Highest Tuberculosis Cases in a Decade According to CDC

In a recent report by the Centers for Disease Control and Prevention (CDC), the United States has witnessed its highest number of tuberculosis (TB) cases in the last decade. With over 9,600 cases reported in 2023, marking a 16% increase from the previous year, this surge has been observed across forty states and among all age groups. This rise in TB cases, the most significant since 2013, comes after a sharp decline at the onset of the COVID-19 pandemic, only to see numbers climbing thereafter.

The CDC attributes this increase partly to a global surge in TB cases, as highlighted by the World Health Organization, which ranked TB just behind COVID-19 among infectious fatal diseases worldwide in 2022. Factors such as heightened international migration and post-pandemic travel have also contributed to this trend. Additionally, illnesses that compromise the immune system can trigger latent TB infections to become active, further complicating the situation.

Dr. Philip LoBue, director of the CDC's Division of Tuberculosis Elimination, expressed that while an increase was anticipated, the actual figures exceeded expectations. Despite this uptick, it's important to note that both the number and rate of new TB cases annually in the U.S. are still lower than historical figures and compared to many other countries.

Tuberculosis is primarily a bacterial infection targeting the lungs and spreads through airborne particles from coughs or sneezes. Without proper treatment, TB can be deadly. The disease was a major cause of death in the late 1800s in the United States and Europe until advancements in antibiotics and public health initiatives significantly reduced its impact.

The 2023 statistics reflect diagnosed cases rather than new infections, with an estimated 85% of these individuals having been infected at least a year or two prior. These cases represent latent TB infections where the bacteria remain dormant until activated by factors such as weakened immune systems due to other illnesses or certain medications.

Nicole Skaggs, a property manager from Bothell, Washington, shared her experience of being infected in 2020 but not developing symptoms until after contracting COVID-19 in 2022. This highlights concerns regarding COVID-19's potential role in reactivating latent TB infections—a question still under investigation by scientists.

As for future trends in TB cases, Dr. LoBue mentioned that it's too early for predictions. However, efforts to combat TB are ongoing, with new vaccines under development and public health workers exploring innovative prevention strategies. New York City has responded to a 28% increase in TB cases by employing case managers and community health workers while adopting video monitoring for medication adherence.

Despite these initiatives, challenges remain such as stagnant federal funding for state and local TB control efforts and occasional shortages of key antibiotics. Moreover, drug-resistant strains of TB have emerged in some instances, adding another layer of complexity to the fight against this infectious disease.